Skye Bioscience, Inc. (SKYE)
Healthcare
Biotechnology
0.57 $
-2.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Skye Bioscience, Inc. (SKYE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -8.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.0 | -4.1 | -3.8 | -4.7 | -7.1 | -5.3 | -8.2 | -9,185 | -11 | -13 | -9.8 | -8.6 | -42 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | -177 | 0.2 | -176 | |
| 0.1 | 0.2 | 0.6 | 2.5 | 1.8 | 1.9 | 2.1 | 2.2 | 2.0 | 1.9 | -2,198 | 1.5 | -2,193 | |
| 0.1 | 21 | – | – | – | – | – | – | – | – | – | – | – | |
| 1.0 | -0.6 | -0.1 | -1.3 | -1.6 | 1.1 | -0.9 | -0.5 | 4.7 | -2.6 | 3.1 | 2.3 | 7.5 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.5 | 0.1 | 6.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 1.1 | 1.1 | 0.0 | 1.1 | 0.0 | -1.4 | 0.1 | -12,809 | -12 | 8.0 | -2.8 | 11 | 4.2 | |
| -0.1 | 4.9 | – | – | – | 0.0 | 0.0 | 0.0 | – | – | – | -0.1 | – | |
| -0.1 | 17 | 0.0 | 86 | -2.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | |
| -2.1 | 14 | -3.9 | 82 | -9.2 | -6.7 | -8.1 | -21,994 | -23 | -5.4 | -13 | 2.3 | -38 | |
| -2.0 | -4.1 | -3.9 | -4.7 | -7.1 | -6.8 | -8.2 | -9,192 | -11 | -13 | -9.8 | -8.6 | -42 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.